# A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

> **NCT02875340** · PHASE2 · COMPLETED · sponsor: **ValiSeek Limited** · enrollment: 8 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Adenocarcinoma

## Interventions

- **DRUG:** VAL401

## Key facts

- **NCT ID:** NCT02875340
- **Lead sponsor:** ValiSeek Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02875340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02875340, "A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02875340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*